Author Disclosures for Late-Breaking Abstracts

Disclosures for 2015 AAAAI Annual Meeting Late-Breaking Abstracts Albers, Frank: GSK, L7 Allekotte, Silke: Nothing to disclose, L24 Ashley, Sarah: Nothing to disclose, L9 Castro, Mario: GSK, IPS/Holaira, Elsevier, Sanofi-Aventis, Genentech, Sparo, INC, Vectura, Amgen, Neostem, KaloBios, Ception/Cephalon/ Teva, Teva, Boston Scientific, Novartis, Asthmatx/Boston Scientific, Medimmune, Boehringer-Ingelheim, L1 Cullen, Valerie: NeuroPhage Pharmaceuticals, Aldeyra Therapeutics, L11 Dhanapala, Pathum: Nothing to disclose, L20 Dorsey, Morna: Sigma-Tau Pharmaceuticals, CSL Behring, L8 Druey, Kirk: Nothing to disclose, L25 Farkas, Henriette: Swedish Orphan Biovitrum, Shire, CSL Behhring, L12 Gandhi, Prasanthi: Inspirotec LLC, L10 Gerace, Kali: Nothing to disclose, L15 Hartog, Anita: Nothing to disclose, L17 Ingram, Jennifer: Nothing to disclose, L3 Kim, Dokyun: Nothing to disclose, L27 Kim, Seom Tae: Nothing to disclose, L23 Knight, John: Nothing to disclose, L2 Levin, Michael: Nothing to disclose, L19 Lu, Wen: Nothing to disclose, L4 Mahajan, Avanika: Nothing to disclose, L26 Mansi, Marta: Nothing to disclose, L13 Mathias, Rasika: Nothing to disclose, L30 McWilliam, Vicki: Nothing to disclose, L18 Muehling, Lyndsey: Nothing to disclose, L5 Patterson, Amber: Nothing to disclose, L22 Perez Sanchez, Natalia: Nothing to disclose, L16 Peters, Rachel: Nothing to disclose, L29 Prazma, Charlene: GlaxoSmithKline, L6 Sampson, Hugh: ThermoFisher Scientific, Danone Research Scientific Advisory Board, Sanofi-Aventis US, LLC, Genentech, Regeneron Pharmaceuticals, UpToDate, Allertein Therapeutics, L28 Silverman, Susanna: Nothing to disclose, L14 Tung, Hui-Ying: Nothing to disclose, L31 Windt, Mark: Nothing to disclose, L21 Xu, Ting: Nothing to disclose, L32